-
Clinical Applications and Therapeutic Mechanisms of Chinese Herbal Medicine Yiaikang Capsules in Treating Acquired Immune Deficiency Syndrome
04 Jul 2025 21:39 GMT
… necessary to find new drugs or treatments, such as traditional … TCM preparations have been developed to treat AIDS, many of which … Life (QoL), Survival Rate, Anemia, and Lung Infections
YAK … in treating aids based on network pharmacology. New Chin Med. 2020 …
-
Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study
04 Jul 2025 14:41 GMT
… Nix-TB trial. Myelosuppression (anemia, leukopenia, … treatment outcomes.7 Therefore, there is an urgent need to develop safer drugs … Trial Team. treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med … tolerability, and pharmacokinetics of MRX-I …
-
Jazz Pharmaceuticals Gets EU Approval for Ziihera to Treat Advanced HER2-Positive Biliary Tract Cancer
03 Jul 2025 18:35 GMT
… Phase 3 HERIZON-BTC-302 trial evaluating zanidatamab combined with … infusion-related reactions, abdominal pain, anemia, and fatigue, with serious adverse … previously had limited treatment options,” said Robert Iannone, Jazz Pharmaceuticals’ chief medical …
-
Biosimilar SB12 Matches Eculizumab in PNH Treatment Across Diverse Patient Groups
03 Jul 2025 13:51 GMT
… eculizumab (Soliris) for treating complement inhibitor-naïve patients … can lead to hemolytic anemia, chronic kidney disease, … are at risk of developing PNH.
PNH arises from … hemoglobinuria (PNH): symptoms & treatment. Cleveland Clinic. April 25, …
-
FDA Grants Accelerated Approval to Sunvozertinib for Metastatic NSCLC With EGFR Exon 20 Insertion Mutations
03 Jul 2025 03:02 GMT
… FDA has granted accelerated approval to sunvozertinib (Zegfrovy) for the treatment … phosphokinase levels (10.8%), anemia (3.6%), rash ( … .fda.gov/drugs/resources-information-approved-drugs/fda … mutations. News Release. Dizal Pharma. April 7, 2024. …
-
Sunvozertinib Granted FDA Accelerated Approval in EGFR Exon 20+ NSCLC
03 Jul 2025 00:15 GMT
… randomization phase 2 WU-KONG1B trial (NCT03974022). The overall … oral drug would offer a convenient and safe treatment option … phosphokinase levels (10.8%), anemia (3.6%), rash (3 … www.fda.gov/drugs/resources-information-approved-drugs/fda- …
-
JCR Pharmaceuticals Announces the Achievement of Enrollment in the JR-141 Global Phase III Clinical Trial
02 Jul 2025 15:31 GMT
… III clinical trial is ongoing … development program, as the Hunter syndrome community needs a therapy that treats … specialty pharmaceutical company that develops treatments that … anemia. Our investigational products in development worldwide are aimed at treating …
-
Birth Control Pill Classified Carcinogenic: What We Know
02 Jul 2025 12:46 GMT
… extended-use pills. Of these pills, the combined pill is the … be taken in the treatment of anemia by reducing menstrual bleeding … combined contraceptive pill and an increased risk of developing breast … discuss risks of all medications with their patients, but …
-
Obrixtamig Plus Topotecan Shows Tolerability, Efficacy in Advanced ES-SCLC
04 Jul 2025 20:15 GMT
… (52%), lymphocyte count decreases (32%), anemia (24%), and fatigue (16%). Furthermore … the Early Clinical Trial Unit and of the Trial Management National Center … further investigation of the combination treatment.”
Patients with histologically or cytologically …
-
Beyond supplements : Homoeopathy in the management of iron deficiency anaemia
04 Jul 2025 07:44 GMT
… and successful treatment for iron deficiency anemia remains woefully … for survival, physical development, mental development, effectiveness and productivity, … TG. Iron deficiency anemia. Med Clin North Am. … . Neuropsychiatr
Dis Treat 10:10:2087–2095 …